These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34193136)

  • 1. Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma.
    Zhang Y; Liu Q; Liu J; Liao Q
    Cancer Cell Int; 2021 Jun; 21(1):327. PubMed ID: 34193136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
    Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
    Front Oncol; 2022; 12():827051. PubMed ID: 35433491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration.
    Zhang R; Liu Q; Peng J; Wang M; Li T; Liu J; Cui M; Zhang X; Gao X; Liao Q; Zhao Y
    J Cancer; 2020; 11(9):2371-2381. PubMed ID: 32201508
    [No Abstract]   [Full Text] [Related]  

  • 6. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma.
    Rezagholizadeh F; Tajik F; Talebi M; Taha SR; Shariat Zadeh M; Farhangnia P; Hosseini HS; Nazari A; Mollazadeh Ghomi S; Kamrani Mousavi SM; Haeri Moghaddam N; Khorramdelazad H; Joghataei MT; Safari E
    Front Immunol; 2024; 15():1283364. PubMed ID: 38357542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma.
    Zhang Y; Liu Q; Cui M; Wang M; Hua S; Gao J; Liao Q
    Front Immunol; 2021; 12():774435. PubMed ID: 35046938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
    Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of B cell transposition gene 3 in pancreatic ductal adenocarcinoma and its prognostic value].
    Chen J; Zhou ZC; Liu WB; Wang J; Chen XJ; Shen YY; Zhong ZX
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):863-867. PubMed ID: 29136736
    [No Abstract]   [Full Text] [Related]  

  • 15. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis.
    Wang Y; Fang T; Huang L; Wang H; Zhang L; Wang Z; Cui Y
    Biochem Biophys Res Commun; 2018 Jun; 501(1):313-319. PubMed ID: 29738769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
    Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
    Front Oncol; 2020; 10():49. PubMed ID: 32117719
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma.
    Bao J; Xu C; Li B; Wu Z; Shen J; Song P; Peng Q; Hu G
    Front Oncol; 2022; 12():834728. PubMed ID: 35425701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.